$TMGI
Marquie Group, Inc.

2024 Q2 Form 10-Q Financial Statement

#000168316824002554 Filed on April 22, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $177.1K $128.1K
YoY Change 70.44% 84.4%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $140.00 $220.00
YoY Change -39.13% -4.35%
% of Gross Profit
Operating Expenses $177.1K $128.1K
YoY Change 70.44% 84.41%
Operating Profit -$128.1K
YoY Change 84.41%
Interest Expense $251.6K $128.6K
YoY Change -42.17% 25.39%
% of Operating Profit
Other Income/Expense, Net -$330.8K
YoY Change -45.21%
Pretax Income $74.51K -$458.9K
YoY Change -77.5% -31.83%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $74.51K -$458.9K
YoY Change -77.5% -31.83%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 1.411B shares 825.6M shares
Diluted Shares Outstanding 1.211B shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $2.160K
YoY Change 4220.0%
Cash & Equivalents $0.00 $2.162K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $735.00 $882.00
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $2.162K
YoY Change 4704.44%
LONG-TERM ASSETS
Property, Plant & Equipment $740.00 $880.00
YoY Change -20.43% -24.14%
Goodwill
YoY Change
Intangibles $11.17K $11.17K
YoY Change 7.72% 7.72%
Long-Term Investments $6.200M $6.200M
YoY Change 0.0% 0.0%
Other Assets $6.247M $6.247M
YoY Change 0.12% 0.2%
Total Long-Term Assets $6.247M $6.247M
YoY Change 0.12% 0.2%
TOTAL ASSETS
Total Short-Term Assets $0.00 $2.162K
Total Long-Term Assets $6.247M $6.247M
Total Assets $6.247M $6.249M
YoY Change 0.12% 0.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $77.07K $70.66K
YoY Change 52.13% 1.79%
Accrued Expenses $2.230M $2.161M
YoY Change 29.38% 37.2%
Deferred Revenue
YoY Change
Short-Term Debt $3.517M $3.628M
YoY Change -1.09% 3.31%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.031M $6.463M
YoY Change -5.28% -3.44%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.031M $6.463M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $6.031M $6.463M
YoY Change -5.28% -3.44%
SHAREHOLDERS EQUITY
Retained Earnings -$14.86M -$14.94M
YoY Change 1.13% -0.61%
Common Stock $332.6K $141.1K
YoY Change 339.52% 86.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $216.4K -$213.5K
YoY Change
Total Liabilities & Shareholders Equity $6.247M $6.249M
YoY Change 0.12% 0.23%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $74.51K -$458.9K
YoY Change -77.5% -31.83%
Depreciation, Depletion And Amortization $140.00 $220.00
YoY Change -39.13% -4.35%
Cash From Operating Activities $14.40K -$71.47K
YoY Change -119.43% 519.32%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $800.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$7.610K
YoY Change -100.0% -45.64%
Cash From Investing Activities $0.00 -$8.410K
YoY Change -100.0% -39.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -16.57K 79.62K
YoY Change -120.96% 221.05%
NET CHANGE
Cash From Operating Activities 14.40K -71.47K
Cash From Investing Activities 0.000 -8.410K
Cash From Financing Activities -16.57K 79.62K
Net Change In Cash -2.170K -260.0
YoY Change 4240.0% -64.86%
FREE CASH FLOW
Cash From Operating Activities $14.40K -$71.47K
Capital Expenditures $0.00 $800.00
Free Cash Flow $14.40K -$72.27K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Stock Option Down Round Feature Increase Decrease In Equity Amount1
StockOptionDownRoundFeatureIncreaseDecreaseInEquityAmount1
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54163
dei Entity Registrant Name
EntityRegistrantName
The Marquie Group, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2091212
dei Entity Address Address Line1
EntityAddressAddressLine1
7901 4th ST N
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 4000
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33702
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33702
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
351-3021
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1410789824 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2162 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
2162 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
0 usd
CY2024Q1 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
6200000 usd
CY2023Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
6200000 usd
CY2024Q1 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
35237 usd
CY2023Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
28247 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21386 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
882 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
929 usd
CY2024Q1 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
11165 usd
CY2023Q2 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
10365 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6247284 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6239541 usd
CY2024Q1 us-gaap Assets
Assets
6249446 usd
CY2023Q2 us-gaap Assets
Assets
6239541 usd
CY2024Q1 us-gaap Bank Overdrafts
BankOverdrafts
0 usd
CY2023Q2 us-gaap Bank Overdrafts
BankOverdrafts
46 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
70658 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
50664 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
834846 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
578017 usd
CY2024Q1 TMGI Accrued Consulting Fees Related Parties
AccruedConsultingFeesRelatedParties
1105367 usd
CY2023Q2 TMGI Accrued Consulting Fees Related Parties
AccruedConsultingFeesRelatedParties
925367 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
220550 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
60837 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
66794 usd
CY2023Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1465138 usd
CY2023Q2 TMGI Notes Payable To Related Parties Current
NotesPayableToRelatedPartiesCurrent
2090772 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1035998 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6366552 usd
CY2023Q2 us-gaap Liabilities
Liabilities
6366552 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
200 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
200 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
200 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
200 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1410789824 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1410789824 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
756612000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
756612000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
75663 usd
CY2024Q1 TMGI Common Stock Payable
CommonStockPayable
8460 usd
CY2023Q2 TMGI Common Stock Payable
CommonStockPayable
8460 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14575002 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14486896 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14938000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14698030 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-213458 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-127011 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6249446 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6239541 usd
CY2024Q1 us-gaap Revenues
Revenues
0 usd
CY2023Q1 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q1 us-gaap Salaries And Wages
SalariesAndWages
60000 usd
us-gaap Salaries And Wages
SalariesAndWages
180000 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
8096 usd
us-gaap Professional Fees
ProfessionalFees
90303 usd
us-gaap Professional Fees
ProfessionalFees
59209 usd
CY2024Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
40690 usd
CY2023Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
1369 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
102105 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
13370 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
128100 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
69465 usd
us-gaap Operating Expenses
OperatingExpenses
372408 usd
us-gaap Operating Expenses
OperatingExpenses
252579 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-128100 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-69465 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-372408 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-252579 usd
CY2024Q1 TMGI Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
-202283 usd
CY2023Q1 TMGI Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
-501275 usd
TMGI Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
508915 usd
TMGI Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
1349841 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
33131 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
17120 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
82012 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
44614 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
128553 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
102520 usd
us-gaap Interest Expense
InterestExpense
376477 usd
us-gaap Interest Expense
InterestExpense
248263 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-330836 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-603795 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
132438 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1101578 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-458936 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-673260 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-239970 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
848999 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-458936 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-673260 usd
us-gaap Net Income Loss
NetIncomeLoss
-239970 usd
us-gaap Net Income Loss
NetIncomeLoss
848999 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1211131582 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1211131582 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
756612000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
756612000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
941858075 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
941858075 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
451229140 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
451229140 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-127011 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
353082 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
226071 usd
CY2023Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
77111 usd
CY2023Q4 TMGI Common Stock Issued For Standby Equity Agreement
CommonStockIssuedForStandbyEquityAgreement
55731 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-134116 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
224798 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
20680 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-458936 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-213458 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5654677 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-111440 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-5766117 usd
CY2022Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
147507 usd
CY2022Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
4200000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1633699 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
215089 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-673260 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-458171 usd
us-gaap Net Income Loss
NetIncomeLoss
-239970 usd
us-gaap Net Income Loss
NetIncomeLoss
848999 usd
us-gaap Depreciation
Depreciation
667 usd
us-gaap Depreciation
Depreciation
1008 usd
TMGI Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
508915 usd
TMGI Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
1349841 usd
TMGI Amortization Of Debt Discounts
AmortizationOfDebtDiscounts
82012 usd
TMGI Amortization Of Debt Discounts
AmortizationOfDebtDiscounts
44614 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
19994 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
34009 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
288209 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
196715 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
180000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
165300 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-178003 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-59196 usd
TMGI Payments On Music Inventory
PaymentsOnMusicInventory
620 usd
TMGI Payments On Music Inventory
PaymentsOnMusicInventory
-0 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
800 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 usd
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
6990 usd
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
23247 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8410 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23247 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
-46 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
0 usd
TMGI Proceeds From Standby Equity Agreement
ProceedsFromStandbyEquityAgreement
55732 usd
TMGI Proceeds From Standby Equity Agreement
ProceedsFromStandbyEquityAgreement
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
141646 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
94835 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
8757 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
12700 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
188575 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
82135 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2162 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-308 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
353 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2162 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
TMGI Initial Derivative Liability Charged To Debt Discounts
InitialDerivativeLiabilityChargedToDebtDiscounts
76056 usd
TMGI Initial Derivative Liability Charged To Debt Discounts
InitialDerivativeLiabilityChargedToDebtDiscounts
0 usd
TMGI Issuance Of Stock And Promissory Note For Investment In Acquisition
IssuanceOfStockAndPromissoryNoteForInvestmentInAcquisition
0 usd
TMGI Issuance Of Stock And Promissory Note For Investment In Acquisition
IssuanceOfStockAndPromissoryNoteForInvestmentInAcquisition
6200000 usd
TMGI Conversion Of Debt And Accrued Interest Into Common Stock
ConversionOfDebtAndAccruedInterestIntoCommonStock
97791 usd
TMGI Conversion Of Debt And Accrued Interest Into Common Stock
ConversionOfDebtAndAccruedInterestIntoCommonStock
147507 usd
CY2024Q1 TMGI Working Capital
WorkingCapital
6460742 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14938000 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
22268 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
21648 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21386 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20719 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
882 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
929 usd
CY2024Q1 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
620 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
620 usd
us-gaap Depreciation
Depreciation
667 usd
us-gaap Depreciation
Depreciation
1008 usd
CY2024Q1 TMGI Accrued Professional Fees Total Current
AccruedProfessionalFeesTotalCurrent
1325917 usd
CY2023Q2 TMGI Accrued Professional Fees Total Current
AccruedProfessionalFeesTotalCurrent
1145917 usd
CY2023Q2 TMGI Accrued Professional Fees Total Current
AccruedProfessionalFeesTotalCurrent
1145917 usd
CY2022Q2 TMGI Accrued Professional Fees Total Current
AccruedProfessionalFeesTotalCurrent
926217 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
180000 usd
CY2023 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
240000 usd
TMGI Payments To Consultants
PaymentsToConsultants
0 usd
CY2023 TMGI Payments To Consultants
PaymentsToConsultants
-20300 usd
CY2024Q1 TMGI Accrued Professional Fees Total Current
AccruedProfessionalFeesTotalCurrent
1325917 usd
CY2023Q2 TMGI Accrued Professional Fees Total Current
AccruedProfessionalFeesTotalCurrent
1145917 usd
CY2024Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1546330 usd
CY2023Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1465138 usd
CY2024Q1 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1546330 usd
CY2023Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1465138 usd
CY2024Q1 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
0 usd
CY2023Q2 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
0 usd
CY2024Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
1607167 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1531932 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-60837 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-66794 usd
CY2024Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1546330 usd
CY2023Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1465138 usd
CY2024Q1 TMGI Notes Payable Related Parties
NotesPayableRelatedParties
2082015 usd
CY2023Q2 TMGI Notes Payable Related Parties
NotesPayableRelatedParties
2090772 usd
CY2024Q1 TMGI Notes Payable To Related Parties Current
NotesPayableToRelatedPartiesCurrent
2082015 usd
CY2023Q2 TMGI Notes Payable To Related Parties Current
NotesPayableToRelatedPartiesCurrent
2090772 usd
CY2024Q1 TMGI Notes Payable To Related Parties Noncurrent
NotesPayableToRelatedPartiesNoncurrent
0 usd
CY2023Q2 TMGI Notes Payable To Related Parties Noncurrent
NotesPayableToRelatedPartiesNoncurrent
0 usd
CY2024Q1 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
644340 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
603138 usd
CY2023Q2 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
603517 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
1035998 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
603138 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
1035998 usd
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 1,000 reverse split
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
535734689 shares
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
97791 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-002554-index-headers.html Edgar Link pending
0001683168-24-002554-index.html Edgar Link pending
0001683168-24-002554.txt Edgar Link pending
0001683168-24-002554-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
marquie_ex3101.htm Edgar Link pending
marquie_ex3201.htm Edgar Link pending
marquie_i10q-022924.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
marquie_i10q-022924_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmgi-20240229.xsd Edgar Link pending
tmgi-20240229_def.xml Edgar Link unprocessable
tmgi-20240229_lab.xml Edgar Link unprocessable
tmgi-20240229_pre.xml Edgar Link unprocessable
tmgi-20240229_cal.xml Edgar Link unprocessable